Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study
Open Access
- 17 November 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 15 (1), 56-64
- https://doi.org/10.1016/s1474-4422(15)00323-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findingsBrain, 2015
- Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissueAnnals of Neurology, 2015
- Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort studyThe Lancet Neurology, 2015
- Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaJama-Journal Of The American Medical Association, 2015
- Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life SpanJAMA Neurology, 2015
- Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrumBrain, 2015
- Tau imaging: early progress and future directionsThe Lancet Neurology, 2015
- Primary age-related tauopathy (PART): a common pathology associated with human agingActa Neuropathologica, 2014
- Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's diseaseAlzheimer's & Dementia, 2014
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004